Biopharma developing and commercializing therapies for unmet medical needs
Vanda Pharmaceuticals is a Washington, DC-based biopharma company whose hiring is overwhelmingly field-sales focused, with mid-level and manager roles dominating, which points to a commercial push rather than an R&D build-out. Recurring job-post themes around reimbursement and market access show payer navigation is the main friction for its sales force. The stack pairs Salesforce and Power BI on the commercial side with SAS for clinical analytics and an on-prem VMware and Cisco infrastructure.
Vanda Pharmaceuticals is a public biopharmaceutical company founded in 2003 and headquartered in Washington, DC. It develops and commercializes therapies aimed at conditions with significant unmet medical need. The company employs 201–500 people and hires in the United States. Its operations span clinical development, including Phase I–IV studies, analytical and stability work, and a territory-based commercial organization that works with prescribers and payers.
Yes. Sales is by far Vanda's largest hiring area, mostly mid-level and manager territory roles in the United States focused on product access, reimbursement and in-territory product use.
Vanda uses Salesforce, Power BI, SAS, Python, ArcGIS and AWS, alongside Microsoft Exchange, Intune, VMware vSphere, Cisco UCS and ASA, and Dell PowerStore. Web work uses React, Vue, TypeScript and Next.js.
Vanda Pharmaceuticals is headquartered in Washington, DC, United States. It is a public company founded in 2003 with 201–500 employees.
Other companies in the same industry, closest in size
Vanda Pharmaceuticals's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.